rethinkPeptides Search
Menu
Study breakdown

GHRP-2, CRF, and Desmopressin: How Different Peptides Produce Different Stress Hormone Patterns

evidence
The takeaway

GHRP-2, CRF, and desmopressin each produced distinct ACTH response patterns (concordant vs discordant with cortisol), revealing how different peptide stimuli engage the stress axis through different mechanisms.

Key finding

GHRP-2, CRF, and desmopressin each produced distinct ACTH response patterns (concordant vs discordant with cortisol), revealing how different peptide

What the researchers found

GHRP-2, CRF, and desmopressin each produced distinct ACTH response patterns (concordant vs discordant with cortisol), revealing how different peptide stimuli engage the stress axis through different mechanisms.

Why it matters

Relevant for peptide research.

How the study worked

research study.

What this study cannot tell us

See abstract.

How to read the evidence

emerging evidence.

When this study was published

Published in 2010.

The bigger picture

Advances peptide research.

Questions still open

  • Further research needed.

Common questions

What was studied?
GHRP-2, CRF, and Desmopressin: How Different Peptides Produce Different Stress Hormone Patterns
What was found?
GHRP-2, CRF, and desmopressin each produced distinct ACTH response patterns (concordant vs discordant with cortisol), revealing how different peptide stimuli engage the stress axis through different mechanisms.

Read the original research

Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.

Endocrine journal, 57(7), 639-44

Citation

Kimura, Takashi; Shimatsu, Akira; Arimura, Hiroshi; Mori, Hideki; Tokitou, Akinori; Fukudome, Michiyo; Nakazaki, Mitsuhiro; Tei, Chuwa. (2010). Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2.. Endocrine journal, 57(7), 639-44.